Form4insider filings, from the source

SEC Form 4 · accession 0001258693-26-000013

Vaxcyte, Inc. · PCVX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Grant Pickering
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jun 26, 2026
Accepted (ET)
Jun 26, 2026 · 6:49 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001649094

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 26, 2026S6,683$54.275D468,020D
Common StockF3Jun 26, 2026S9,137$55.265D458,883D
Common StockF4Jun 26, 2026S6,417$56.121D452,466D
Common StockF5,F6Jun 26, 2026S312$54.345D134,903IBy Children's Trust
Common StockF7,F6Jun 26, 2026S356$55.226D134,547IBy Children's Trust
Common StockF8,F6Jun 26, 2026S332$55.993D134,215IBy Children's Trust
Common StockF9,F10Jun 26, 2026S207$54.222D135,008IBy Children's Trust
Common StockF11,F10Jun 26, 2026S602$55.297D134,406IBy Children's Trust
Common StockF12,F10Jun 26, 2026S191$56.266D134,215IBy Children's Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses